314 related articles for article (PubMed ID: 17363604)
21. Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo.
Zeng A; Hua H; Liu L; Zhao J
Bioorg Med Chem; 2019 Jun; 27(12):2546-2552. PubMed ID: 30910472
[TBL] [Abstract][Full Text] [Related]
22. Anticancer activity of betulinic acid on MCF-7 tumors in nude mice.
Damle AA; Pawar YP; Narkar AA
Indian J Exp Biol; 2013 Jul; 51(7):485-91. PubMed ID: 23898546
[TBL] [Abstract][Full Text] [Related]
23. Betulinic acid promotes TRAIL function on liver cancer progression inhibition through p53/Caspase-3 signaling activation.
Xu Y; Li J; Li QJ; Feng YL; Pan F
Biomed Pharmacother; 2017 Apr; 88():349-358. PubMed ID: 28119237
[TBL] [Abstract][Full Text] [Related]
24. Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.
Hedrick E; Cheng Y; Jin UH; Kim K; Safe S
Oncotarget; 2016 Apr; 7(16):22245-56. PubMed ID: 26967243
[TBL] [Abstract][Full Text] [Related]
25. Lupeol triterpene, a novel diet-based microtubule targeting agent: disrupts survivin/cFLIP activation in prostate cancer cells.
Saleem M; Murtaza I; Witkowsky O; Kohl AM; Maddodi N
Biochem Biophys Res Commun; 2009 Oct; 388(3):576-82. PubMed ID: 19683515
[TBL] [Abstract][Full Text] [Related]
26. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.
Yang H; Chen D; Cui QC; Yuan X; Dou QP
Cancer Res; 2006 May; 66(9):4758-65. PubMed ID: 16651429
[TBL] [Abstract][Full Text] [Related]
27. Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.
Kim K; Chadalapaka G; Pathi SS; Jin UH; Lee JS; Park YY; Cho SG; Chintharlapalli S; Safe S
Mol Cancer Ther; 2012 Sep; 11(9):1852-62. PubMed ID: 22752225
[TBL] [Abstract][Full Text] [Related]
28. Oxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cells.
Ngan CY; Yamamoto H; Takagi A; Fujie Y; Takemasa I; Ikeda M; Takahashi-Yanaga F; Sasaguri T; Sekimoto M; Matsuura N; Monden M
Cancer Sci; 2008 Jan; 99(1):129-39. PubMed ID: 17949450
[TBL] [Abstract][Full Text] [Related]
29. Betulinic acid induces apoptosis and inhibits metastasis of human renal carcinoma cells in vitro and in vivo.
Yang C; Li Y; Fu L; Jiang T; Meng F
J Cell Biochem; 2018 Nov; 119(10):8611-8622. PubMed ID: 29923216
[TBL] [Abstract][Full Text] [Related]
30. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells.
Selzer E; Pimentel E; Wacheck V; Schlegel W; Pehamberger H; Jansen B; Kodym R
J Invest Dermatol; 2000 May; 114(5):935-40. PubMed ID: 10771474
[TBL] [Abstract][Full Text] [Related]
31. Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP-1 in human multiple myeloma cells.
Pandey MK; Sung B; Aggarwal BB
Int J Cancer; 2010 Jul; 127(2):282-92. PubMed ID: 19937797
[TBL] [Abstract][Full Text] [Related]
32. Betulinic acid, a catalytic inhibitor of topoisomerase I, inhibits reactive oxygen species-mediated apoptotic topoisomerase I-DNA cleavable complex formation in prostate cancer cells but does not affect the process of cell death.
Ganguly A; Das B; Roy A; Sen N; Dasgupta SB; Mukhopadhayay S; Majumder HK
Cancer Res; 2007 Dec; 67(24):11848-58. PubMed ID: 18089815
[TBL] [Abstract][Full Text] [Related]
33. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation.
Tan Y; Yu R; Pezzuto JM
Clin Cancer Res; 2003 Jul; 9(7):2866-75. PubMed ID: 12855667
[TBL] [Abstract][Full Text] [Related]
34. Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells.
Abdelrahim M; Baker CH; Abbruzzese JL; Sheikh-Hamad D; Liu S; Cho SD; Yoon K; Safe S
Cancer Res; 2007 Apr; 67(7):3286-94. PubMed ID: 17409437
[TBL] [Abstract][Full Text] [Related]
35. Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.
Chun JY; Hu Y; Pinder E; Wu J; Li F; Gao AC
Mol Cancer Ther; 2007 Sep; 6(9):2572-80. PubMed ID: 17876054
[TBL] [Abstract][Full Text] [Related]
36. Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo.
Zhou R; Lu Z; Liu K; Guo J; Liu J; Zhou Y; Yang J; Mi M; Xu H
Curr Cancer Drug Targets; 2015; 14(9):860-71. PubMed ID: 25431082
[TBL] [Abstract][Full Text] [Related]
37. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
[TBL] [Abstract][Full Text] [Related]
38. Sp1 and Sp3 regulate basal transcription of the survivin gene.
Xu R; Zhang P; Huang J; Ge S; Lu J; Qian G
Biochem Biophys Res Commun; 2007 Apr; 356(1):286-92. PubMed ID: 17350596
[TBL] [Abstract][Full Text] [Related]
39. Betulinic acid inhibits aminopeptidase N activity.
Melzig MF; Bormann H
Planta Med; 1998 Oct; 64(7):655-7. PubMed ID: 9810272
[TBL] [Abstract][Full Text] [Related]
40. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.
Wei D; Wang L; He Y; Xiong HQ; Abbruzzese JL; Xie K
Cancer Res; 2004 Mar; 64(6):2030-8. PubMed ID: 15026340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]